Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LRRN2 antisense RNA 1 (LRRN2-AS1) is a long non-coding RNA gene, transcribed from the antisense strand near the locus of the LRRN2 gene[1]. Like other antisense lncRNAs, it may play a role in regulating the expression or function of its sense gene LRRN2 by mechanisms that can affect mRNA stability, translation, and epigenetic modification. However, there is very little specific functional or biomedical literature about LRRN2-AS1 itself. Its biological significance, disease associations, and potential as a therapeutic target remain unclear and largely unexplored[1][3][6].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LRRN2 antisense RNA 1 (LRRN2-AS1).